Aortic pressure: current views on clinical and prognostic value of measure
https://doi.org/10.21518/2079-701X-2013-9-26-33
Abstract
Reduction in cardiovascular morbidity and mortality is not always or only owed to antihypertensive effect of treatments. Decrease in systolic blood pressure helped by antihypertensive drugs may be different in the central and peripheral vascular segments, which is largely explained by different pathophysiology of central and peripheral arterial blood pressure. This review is devoted to current views on pathophysiology, diagnostic techniques, medication effects on central blood pressure, clinical and prognostic value of measuring central blood pressure and prospects for its evaluation.
About the Authors
Yu. V. Kotovskaya
Российский университет дружбы народов, Москва
Russian Federation
Russian Federation
Gh. D. Kobalava
Российский университет дружбы народов, Москва
Russian Federation
Russian Federation
References
1. Sleight P, Yusuf S, Pogue J, et al. Blood-pressure reduction and cardiovascular risk in HOPE study. Lancet 2001; 358:2130–2131.
2. Poulter NR, Wedel H, Dahlof B et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial – Blood Pressure Lowering Arm (ASCOT–BPLA). Lancet 2005; 366:907–913.
3. Yusuf S, Sleight P, Pogue J et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342:145–153.
4. Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345:851–860.
5. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345:861–869.
6. Pauca AL, Wallenhaupt SL, Kon ND, Tucker WY. Does radial artery pressure accurately reflect aortic pressure? Chest 1992; 102:1193–1198.
7. London GM, Asmar RG, O’Rourke MF, Safar ME. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004; 43:92–99.
8. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213–1225.
9. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases.Circulation 2003; 107:2864–2869.
10. Яновский М.В. Клинические данные по вопросу о периферическом артериальном сердце. Научн мед 1922; № 10: 121
11. Савицкий Н. Н. Биофизические основы кровообращения и клинические методы изучения гемодинамики// Л.1974.
12. Рогоза А.Н. Механические свойства малых аpтеpий мышечного типа // Диссеpтация на соискание ученой степени к.б.н.АМН СССР ВКНЦ-М., 1982.
13. Хаютин В.М., Рогоза А.Н. Регуляция кровеносных сосудов, порождаемая приложенными к ним механическими силами // Физиология кровообращения: Регуляция кровообращения. – Л.: Наука, 1986, С. 37-64.
14. Цедерс Э.Э., Слуцкий Л.И., Пуриня Б.А. Связь между механическими характеристиками брюшной аорты человека и её биохимическим составом // Механика полимеров. - М., 1975, № 2. - С. 320 - 325.
15. Шендеров С. М., Рогоза А. Н. Миогенный тонус и механика кровеносных сосудов // Физиология человека и животных. – М.: ВИНИТИ, 1979. – Т. 23. – С. 3–45.
16. Fischer GM, Llaurado JG. Collagen and elastin content in canine arteries selected from functionally different vascular beds. Circ Res 1966;19:394–399.
17. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005;45:1050–1055.
18. Laurent S., Cockcroft J., Van Bortel L. et al on behalf of the European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. European Heart Journal 2006: 27, 2588–2605
19. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005;46:1753–1760.
20. Boutouyrie P, Laurent S, Benetos A, Girerd X, Hoeks A, Safar M. Opposite effects of ageing on distal and proximal large arteries in hypertensives. J Hypertens 1992;10(Suppl. 6):S87–S92.
21. Mahmud A., Feely J. Spurious systolic hypertension: fit young men with elastic arteries. Am J Hypertens 2003; 16:229-232
22. Hulsen HT, Nijdam ME, Bos WJ, Uiterwaal CS, Oren A, Grobbee DE, Bots M. Spurious systolic hypertension in young adults; prevalence of high brachial systolic blood pressure and low central pressure and its determinants. J Hypertens 2006; 24:1027–1032.
23. Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932–937.
24. Miyashita H. Clinical Assessment of Central Blood Pressure. Curr Hypertens Rev. 2012;8(2):80-90.
25. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001; 104: 1464–1470.
26. Ferrier KE, Muhlmann MH, Baguet JP, Cameron JD, Jennings GL, Dart AM, Kingwell BA. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 2002; 39:1020–1025.
27. Kontopoulos AG, Athyros VG, Pehlivanidis AN, Demitriadis DS, Papageorgiou AA, Boudoulas H. Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients. Curr Med Res Opin 2003; 19:22–27.
28. Safar ME, Laurent SL, Bouthier JD, London GM, Mimran AR. Effect of converting enzyme inhibitors on hypertensive large arteries in humans. J Hypertens Suppl 1986; 4:S285–S289.
29. Chen CH, Ting CT, Lin SJ, Hsu TL, Yin FC, Siu CO, et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension 1995; 25:1034–1041.
30. Pannier BM, Guerin AP, Marchais SJ, London GM. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension. Clin Exp Pharmacol Physiol 2001; 28:1074–1077
31. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004; 17:118–123.
32. Asmar RG, London GM, O’Rourke ME, Safar ME, REASON Project Coordinators, Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001;38:922–926.
33. Saba PS, Roman MJ, Pini R, Spitzer M, Ganau A, Devereux RB. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993; 22:1873–1880.
34. Lekakis JP, Zakopoulos NA, Protogerou AD, Kotsis VT, Papaioannou TG, Stamatelopoulos KS, et al. Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness. Int J Cardiol 2004; 97:29–33.
35. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation 1999; 100:1387–1393.
36. Nishijima T, Nakayama Y, Tsumura K, Yamashita N, Yoshimaru K, Ueda H, et al. Pulsatility of ascending aortic blood pressure waveform is associated with an increased risk of coronary heart disease. Am J Hypertens 2001; 14:469–473.
37. Danchin N, Benetos A, Lopez-Sublet M, Demicheli T, Safar M, Aortic pulse pressure is related to the presence and extent artery disease in men undergoing diagnostic coronary angiography: a multicenter study. Am J Hypertens 2004; 17:129–133.
38. Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Perez G, Mendez AJ. Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease. Am J Cardiol 2005; 96:645–648.
39. Safar ME, Blacher J, Pannier B, Guerin A, Marchais SJ, Guyonvarc’h PM, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002;39:735–738.
40. Papaioannou TG, Karatzis EN, Papamichael CM, Karatzis KN, Zakopoulos NA, Lekakis JP, et al. Circadian variation of arterial pressure wave reflections. Am J Hypertens 2006; 19:259–263.
41. Roman M.J., Kizer J/R. Ali T. et al Central blood pressure better predicts cardiovascular events than does peripheral blood pressure: The Strong Heart Study.Circulation 2005 ; 112 (suppl II) :II-778
42. Dart AM, Gatzka CD, Kingwell BA, Willson K, Cameron JD, Liang YL, Berry KL, Wing LM, Reid CM, Ryan P, Beilin LJ, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Morgan TO, West MJ. Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension 2006;47:785–790.
43. Sharman JE, Marwick TH, Abhayaratna WP, Stowasser M. Rationale and Design of a Randomized Study to Determine the Value of Central Blood Pressure for Guiding Management of Hypertension The BP GUIDE Study. Am Heart J. 2012;163(5):761-767.
44. Кобалава Ж.Д., Котовская Ю.В., Ахметов Р.Е.. Артериальная ригидность и центральное давление: новые патофизиологические и лечебные концепции. Артериальная гипертензия. 2010. Т. 16. № 2. С. 126-133.
45. Nilsson P. M., Boutouyrie P., Laurent S. Vascular Aging: A Tale of EVA and ADAM in Cardiovascular Risk Assessment and Prevention Hypertension 2009;54;3-10
46. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002;106:2085–2090.
47. Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM, Pannier B, Benetos A. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 2006; 47:72–75.
48. Smith JC, Page MD, John R, Wheeler MH, Cockcroft JR, Scanlon MF, Davies JS. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000; 85:3515–3519
49. Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H, Webb DJ, et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol 2002; 39:1005–1011.
50. Tryfonopoulos D, Anastasiou E, Protogerou A, Papaioannou T, Lily K, Dagre A, et al. Arterial stiffness in type 1 diabetes mellitus is aggravated by autoimmune thyroid disease. J Endocrinol Invest 2005; 28:616–622.
51. Klocke R, Cockcroft JR, Taylor GJ, Hall IR, Blake DR. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 2003; 62:414–418.
52. Waddell TK, Dart AM, Gatzka CD, Cameron JD, Kingwell BA. Women exhibit a greater age-related increase in proximal aortic stiffness than men. J Hypertens 2001; 19:2205–2212.
53. Wilkinson IB, Franklin SS, Hall IR, Tyrrell S, Cockcroft JR. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension 2001;38:1461–1466.
54. Mancia G, de Backer G, Dominiczak A, Cifkova R., Fagard R., Germano G . et al . 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105–1187
55. Mancia G., Fagard R., Narkiewicz K. et al .2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 2013; 31 (7): 1281-1357.
Review
For citations:
Kotovskaya YV, Kobalava GD. Aortic pressure: current views on clinical and prognostic value of measure. Meditsinskiy sovet = Medical Council. 2013;(9):26-33. (In Russ.) https://doi.org/10.21518/2079-701X-2013-9-26-33
Views:
588
Email this article 